Elad Fraiman

Elad Fraiman

Auto-generated profile, based on publicly available information

Elad Fraiman

Case Western Reserve University School of Medicine , Cleveland, OH 44106

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 March 2023 in The Journal of Sexual Medicine
Verified
Journal Article
Closed access
PDF file
FGFrances W Grimstad
Frances W Grimstad
EFElad Fraiman
Elad Fraiman
GGGarrett Garborcauskas
Garrett Garborcauskas
CFCecile A Ferrando
Cecile A Ferrando
As more transgender and gender-diverse patients undergo hysterectomy, gaps in knowledge remain about how testosterone dosing or other physiologic parameters change following surgery and how these are influenced by concomitant oophorectomy. The aims of this study were to determine the incidence of testosterone dosing change after gender-affirming hysterectomy and to compare this incidence between patients who underwent oophorectomy and ovarian preservation. This multicenter retrospective cohort study consisted of transmasculine patients who underwent hysterectomy for gender affirmation. Outcome measures included testosterone dosing changes at least 3 months following hysterectomy, as identified by clinical documentation, as well as clinical and laboratory parameters assessed for a change after hysterectomy: free and total testosterone, estradiol, hemoglobin, hematocrit, total cholesterol, weight, and blood pressure. Of the 50 patients, 32 (64%) underwent bilateral oophorectomy, 10 (20%) unilateral oophorectomy, and 8 (16%) maintained both ovaries. Eight percent (n = 4) changed testosterone dosing following hysterectomy. Those who underwent bilateral oophorectomy were no more likely to change their testosterone dose than those who did not (P = .09). Those who also used menstrual suppression were 1.31 times more likely to change doses of testosterone after hysterectomy (95% CI, 1.09-1.82; P = .003). For those who had pre- and posthysterectomy laboratory and clinical values, the majority saw no clinically significant change. However, among patients who underwent bilateral oophorectomy, the calculated free testosterone increased by 90.1 ± 288.4 ng/dL (mean ± SD), and estradiol dropped by 20.2 ± 29.0 pg/mL. In a field where access to care can be a significant barrier, there is unlikely to be a need for routine reassessment of testosterone dose or laboratory parameters following hysterectomy, whether or not a bilateral oophorectomy occurs. Limitations of the study include its retrospective nature and the lack of consistent clinical laboratory testing, which resulted in limited data about any given hormonal change. The heterogeneity of our population limited the number of patients undergoing or not undergoing oophorectomy; however, it allowed our study to more truly reflect a clinical environment. In a multisite cohort of individuals who underwent hysterectomy for gender affirmation, few patients changed testosterone dosing after surgery. In addition, dosing change was not associated with the presence or absence of bilateral oophorectomy, and most measured laboratory values remained consistent following hysterectomy.

14 July 2023 in The Journal of Sexual Medicine
Verified
Journal Article
Open access
PDF file
EFElad Fraiman
Elad Fraiman
CGCarly Goldblatt
Carly Goldblatt
MLMatthew Loria
Matthew Loria
KMKirtishri Mishra
Kirtishri Mishra
RPRachel Pope
Rachel Pope
Background: Providers are currently using surveys designed for cisgender women and/or creating their own questionnaires to evaluate the sexual function and satisfaction (SFS) of transgender women postvaginoplasty (TWPV), despite the marked difference in anatomy and lived experience between these groups. Aim: To evaluate the appropriateness of the current assays that have been validated in cisgender women and to assess their applicability in studying SFS in TWPV. Methods: Surveys assessing female SFS that were validated in English speakers in North America were compiled and reviewed. Percentages reflect the proportion of surveys that asked questions deemed relevant or irrelevant for TWPV. Assessed variables included questions about endogenous lubrication, pain/discomfort with penetration, and other sexual activity. Outcomes: Outcomes of interest were questions that fell into 1 of 2 categories: questions irrelevant to TWPV (present/irrelevant) and those relevant for TWPV (present/relevant). Results: All surveys contained present/irrelevant questions. Endogenous lubrication—a property of the natal vagina that may not be present in the neovagina—was the primary present/irrelevant question and was asked in 69.2% of the surveys. Vaginal pain, a present/relevant question, was assessed in 46.2% of surveys. Furthermore, questions requiring a partnered relationship to answer were asked in 61.5% of surveys, which may detract from the assessment of SFS in individuals who do not have sexual partners. Notably, there was also a lack of questions important for evaluating SFS in TWPV, such as assessing satisfaction of the caliber and depth of the neovagina, erogenous stimulation of the prostate during insertive intercourse, and cosmetic appearance of the vulva. Clinical Implications: This analysis raises concerns about the clinician’s ability to meaningfully assess SFS in TWPV using the tools available. Strengths and Limitations: This article is the first of its kind to qualitatively assess the applicability of currently validated SFS questionnaires in TWPV. Limitations include the inability to draw definitive conclusions due to the qualitative nature of the study and the possibility of missing complex biopsychosocial factors, as trans individuals were not directly involved in the assessments of applicability. Conclusion: Given that the existing surveys are not designed to assess the SFS of TWPV, we call for the development of a validated survey for this population, which is in line with the precedent set by several other questionnaires validated for similarly specific populations.

25 August 2024 in Urology
Verified
Journal Article
Closed access
EFElad Fraiman
Elad Fraiman
DNDevika Nandwana
Devika Nandwana
MLMatthew Loria
Matthew Loria
KCKelly Chambers
Kelly Chambers
SRStephen Rhodes
Stephen Rhodes
KMKirtishri Mishra
Kirtishri Mishra

2 February 2025 in Sexual Medicine
Verified
Journal Article
Open access
ASAmine Sahmoud
Amine Sahmoud
RRRebekah Russell
Rebekah Russell
EKErika L Kelley
Erika L Kelley
EFElad Fraiman
Elad Fraiman
CGCarly Goldblatt
Carly Goldblatt
RPRachel Pope
Rachel Pope
Background: Transgender and gender diverse individuals (TGDIs) are people whose gender identity is not in line with their sex assigned at birth, but current surveys used for cisgender patients addressing sexual satisfaction and function (SFS) do not fit the needs of this unique population. Aim: The authors of this project sought to create and validate a new comprehensive survey in North American English that differs from the current options for TGDI post-vaginoplasty. Materials and methods: Using the current literature on SFS as a foundation, a 26-item survey was created and distributed to 16 TGDI at least 3 months post-vaginoplasty. Feedback and review for content validity took place in the forms of interviews with the 16 TGDI, an expert panel, and the creation of a community advisory board. Outcomes: Feedback was incorporated to transform the original 26-item questionnaire into a 32-question survey with eight domains, named the SatisFunction Survey Post-Vaginoplasty, which represents the preliminary development and content validity of the survey, with its clinical use not recommended until further validation steps are completed. Results: Feedback focused on improving the clarity of questions to address sexual vs non-sexual behaviors, providing definitions of terms in the question stems for improved user understanding, including more questions on specific anatomic locations, addressing gender dysphoria as it relates to genital self-image, specifying type of vaginoplasty and only including questions relevant to those with or without a vaginal canal. Clinical implications: The authors foresee clinical use of the survey for recurrent assessment in the postoperative period as well as post-revision. Strength and limitations: Community-based research is essential in developing an assessment tool tailored to the unique needs of a specific population. This study presents the findings of preliminary content validation but requires further validation before clinical use, and is limited by a small sample size from a single-site institution. Conclusion: Future directions involve completing the validation process for the survey with distribution to a larger TGDI population with other validated surveys with a subsequent cohort interview to address construct and divergent validity as well as reliability.

25 May 2023 in Current Sexual Health Reports
Verified
Journal Article
Closed access
PDF file
EFElad Fraiman
Elad Fraiman
KCKelly Chambers
Kelly Chambers
DNDevika Nandwana
Devika Nandwana
MLMatthew Loria
Matthew Loria
VMVivian McCallum
Vivian McCallum
SGShubham Gupta
Shubham Gupta

23 April 2024 in Sexual Medicine Reviews
Verified
Journal Article
Closed access
PDF file
MLMatthew Loria
Matthew Loria
CDChloe Van Dorn
Chloe Van Dorn
ABAidan Bobrow
Aidan Bobrow
AGAishwarya Gautam
Aishwarya Gautam
EFElad Fraiman
Elad Fraiman
KMKirtishri Mishra
Kirtishri Mishra
Introduction: For transmasculine spectrum individuals, there is a lack of validated surveys to assess sexual well-being (SWB) post–genital gender-affirming surgery. Currently, either providers are designing their own SWB surveys or surveys designed for cisgender men are being used. Objective: This study investigated the applicability of SWB surveys validated for cisgender men to transmasculine spectrum individuals post–genital gender-affirming surgery (TMSX). Recognizing the paucity of validated tools for assessing SWB in transmasculine individuals post–genital gender-affirming surgery (TMSX), we evaluated current surveys for their inclusiveness and relevance to this population. Methods: Our methodology involved analyzing surveys validated in English-speaking North American cisgender men. We conducted a systematic review, yielding 31 surveys, out of which 12 met our inclusion criteria. These were then assessed against the 10 domains of holistic SWB as identified by Özer et al. Each survey was scored based on its reflection of these domains, thus generating an SWB score. Additionally, we performed a thematic analysis to identify areas needing modification for better applicability to TMSX. Results: Our findings indicate an average SWB score of 5.17 out of 10 across the surveys. The surveys predominantly addressed sexual function, with a marked underrepresentation of domains like quality of life, sexuality, and sexual pleasure. This underscores the tendency of these surveys to focus more on the biological mechanisms of sex, rather than on a nuanced biopsychosocial understanding. Thematic analysis revealed significant gaps, such as the irrelevance of questions about erections and ejaculations for TMSX, and the need for greater emphasis on psychosocial factors. Conclusion: Given these gaps and the inadequacy of most cisnormative surveys, we recommend the creation of a novel, validated SWB survey specifically for TMSX. This should be developed in collaboration with a multidisciplinary panel and TMSX community advisory board, ensuring a tool that truly reflects the unique SWB needs of this population.